Nitta Gelatin Inc. · TSE:4977
Nitta Gelatin — FY2024 Earnings Presentation
10 slides from Nitta Gelatin's earnings presentation, May 15, 2024
Slide 1: Financial Results (Fiscal Year Ended March 31, 2024)
Financial Results （Fiscal Year Ended March 31, 2024） May 15, 2024 Securities code: 4977
Slide 2: Fiscal 2024 Consolidated Statements of Income
Fiscal 2024 Consolidated Statements of Income ⚫ Net sales rose. Operating income decreased mainly due to worsening productivity at Nitta Gelatin USA, Inc. but ordinary income increased due to foreign exchange gains of ¥537 million recorded under non-operating income. ⚫ An extraordinary loss of ¥2,43
Slide 3: Fiscal 2024 Sales Summary
Fiscal 2024 Sales Summary ⚫ By Sales Category: Food Solutions benefited from increased demand for gelatin for gummy candies in Japan, as well as progress in price revisions. In Health Support, sales of gelatin for capsules grew both in Japan and overseas. Specialties sales of by-products overseas de
Slide 4: Fiscal 2024 Consolidated Balance Sheets
Fiscal 2024 Consolidated Balance Sheets ⚫ Assets: Cash and deposits increased due to higher sales and improved capital efficiency. Inventories, while still at a high level, decreased compared to the end of the previous fiscal year. Property, plant and equipment decreased mainly due to impairment los
Slide 5: Fiscal 2024 Consolidated Statements of Cash Flows
Fiscal 2024 Consolidated Statements of Cash Flows ⚫ Operating cash flows: Increased due to impairment losses, depreciation and amortization, and decrease in inventories, etc. ⚫ Investing cash flows: Outflows increased due to the acquisition of property, plant and equipment for the maintenance and up
Slide 6: Impacts of Production Stoppage of Consolidated Subsidiaries
Impacts of Production Stoppage of Consolidated Subsidiaries ■Nitta Gelatin USA, Inc. ⚫ Nitta Gelatin USA, Inc. has been manufacturing and selling porcine gelatin, porcine collagen peptide, and other products in North America. However, it discontinued production as of January 2024, as it will be diff
Slide 7: Fiscal 2025 Earnings Forecast
Fiscal 2025 Earnings Forecast ⚫ Although overall net sales are expected to decline due to lower sales following the discontinuation of production at Nitta Gelatin USA, Inc., sales in Japan and India are expected to grow on the back of strong demand for gelatin for gummy candies and for capsules. ⚫ I
Slide 8: Situation of Capital Investment and Dividends
Situation of Capital Investment and Dividends ⚫ For fiscal 2025, we plan to make strategic investments, such as increasing collagen peptide production capacity at Indian bases and introducing ERP, as well as investments in upgrading existing facilities for the purpose of stable production, efficienc
Slide 9: (Reference materials) Trend in Consolidated Performance
(Reference materials) Trend in Consolidated Performance Operating income and net income Net sales (Millions of yen) (Millions of yen) 39,186 40,420 39,000 4,000 36,464 34,543 40,000 30,514 31,783 3,000 3,000 30,000 2,259 1,690 1,836 2,000 1,560 1,558 1,600 20,000 1,356 989 1,000 898 742 726 10,000 0
Slide 10: Notice
Notice The opinions, outlooks, and forecasts contained in this material are based on the judgment of the Company at the time of the preparation of this document. The Company does not guarantee the accuracy of the information. Due to various factors such as market environment, etc., future results ma